Clinical Trials Browser

Phase 2 × Immunoblastic Lymphadenopathy × Thalidomide × Clear all

NCT00958854 2013-08-26

Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

Phase 2 Unknown

Immunoblastic Lymphadenopathy, Lymphoma